Vise Technologies, Inc. Teva Pharmaceutical Industries LTD Transaction History
Vise Technologies, Inc.
- $1.17 Billion
- Q4 2024
A detailed history of Vise Technologies, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Vise Technologies, Inc. holds 13,287 shares of TEVA stock, worth $233,718. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,287Holding current value
$233,718% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
626MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$756 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$687 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$665 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$513 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$490 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.5B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...